AstraZeneca's Hypertension Drug Baxfendy Receives US FDA Approval

AstraZeneca has announced that its hypertension drug, Baxfendy, has received approval from the U.S. Food and Drug Administration (FDA). This approval marks a significant step for the treatment of hypertension.